A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients. - Wikidata - wikimedia - TriplyDB

A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients.

A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients.

http://www.wikidata.org/entity/Q37457573

about

Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections Bioinformatics: the next frontier of metabolomics The systemic nature of CKD.Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.Classification of osteoarthritis phenotypes by metabolomics analysis.Metabolomics of renal venous plasma from individuals with unilateral renal artery stenosis and essential hypertension Differential effects of oral and intravenous l-carnitine on serum lipids: is the microbiota the answer?Metabolomic fingerprint of heart failure with preserved ejection fraction.Cross-sectional examination of metabolites and metabolic phenotypes in uremia.An Enlarged Profile of Uremic Solutes.Metabolomics and renal disease.Long-chain Acylcarnitines Reduce Lung Function by Inhibiting Pulmonary Surfactant.Undernutrition during pregnancy in mice leads to dysfunctional cardiac muscle respiration in adult offspring Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension.Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions.Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.Microbiota-Dependent Metabolite Trimethylamine N-Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA)A systematic survey of lipids across mouse tissues.Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.An overview of renal metabolomics.Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients.Associations between acylcarnitine to free carnitine ratio and adverse prognosis in heart failure patients with reduced or preserved ejection fraction.Plasma metabolomics profiling of maintenance hemodialysis based on capillary electrophoresis - time of flight mass spectrometry.Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol.Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study.Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis.Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study.Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review.Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertension.Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles.Interventional Left Atrial Appendage Closure Affects the Metabolism of Acylcarnitines.Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate.A Systems-Level View of Renal Metabolomics.Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.Association between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients

P2860

Q26782662-308E87FB-A8B9-45AE-9055-58721634AAAD Q28652509-7FEBA3B2-4E81-47E4-B1C9-3D9356B150C3 Q30234695-BC20A41B-75BF-474A-8300-FF2485B63639 Q33677357-3A0F6043-6F02-49DD-8444-244348A88CD1 Q33749467-82B7D6F2-3709-4C6A-800E-5342AB3FBA7A Q34573194-BEBCCEB3-4E22-4A39-A868-712EA7C77E31 Q35161725-C367776E-CE2D-4697-A92A-368A98BF779C Q35232161-C69ABC7D-169B-4255-9C87-5FB8FAC05D74 Q35641415-8686B6FF-3365-4674-A47F-E9C9B46353FE Q35684721-296EE89F-9B81-4DB8-87FD-0DD6BEEF4978 Q35759240-38A45333-A108-440E-BA83-BEE9A547FE56 Q35778649-D6844BC2-2D95-4A31-8F1B-470D9225A1B2 Q36093092-60882C71-FCD1-40EC-89C5-ADE5DD04BDA9 Q36185155-4425C496-A28E-4E89-891D-7C0CF54693EA Q36909329-46196A45-734A-4E06-B5FC-097B1784C7B5 Q36937651-F2E80044-56D9-44B3-B873-2CA4ACD4DCF4 Q37240351-3831E011-A7A2-48AD-B589-FCFDAD96373A Q37434694-8F7421D2-4F7F-4F36-9187-CF5E9BE09A94 Q37707634-3888589C-2AB0-4D30-B8A7-3F084B3BEBED Q38381282-72FFCF01-2563-49FD-8082-4671BA965417 Q38815590-BF543767-FAC9-4B28-AFFD-F2E273F131AE Q38815775-A78E01E9-1F99-42DE-ABB7-B7E4EF9079F4 Q40642197-20C97D55-C206-47FE-89B7-7FCBB23295AB Q41239162-E1F668AC-14ED-4EFC-9896-E0A88D914976 Q41420103-80DE9545-B3C1-4D7A-A7F7-C4B84EE071A6 Q41653342-DDEE5F86-BB37-4A26-82ED-D6D805DD2E22 Q42042957-21F5D60C-FFD9-4A69-B3C3-CCDBB4A3A16A Q42333907-CD6DAB4F-EA8E-4361-B1DF-4962881CE2CD Q46231230-9C771E24-0F8E-4593-A500-F49755EB801E Q47135542-EAB7F8B1-4AB6-405A-A46B-C214111BE792 Q47153055-C5180987-49A8-4E71-AF13-725B377BEB55 Q47168939-D1939BA7-2556-4AFC-820C-C184BF073C1B Q50042244-B82D0E47-0DBD-4F56-A7EA-64257EDED1BA Q50133651-3169110A-57E5-4D38-9DE1-0577A3F227D3 Q51412140-667C00F3-C2F0-4E58-AA5E-EC340727E50A Q52336692-912CC27E-1737-4E62-87F9-22AC4FFB6749 Q52575994-86C66D94-6CC1-4EB1-9914-77AED0539821 Q58723478-F9874055-8B5B-4BC6-8045-6B7A2FC742D1

P2860

A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients.

http://www.wikidata.org/entity/Q37457573

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A plasma long-chain acylcarnit ...... in incident dialysis patients.

@en

A plasma long-chain acylcarnit ...... in incident dialysis patients.

@nl

type

label

A plasma long-chain acylcarnit ...... in incident dialysis patients.

@en

A plasma long-chain acylcarnit ...... in incident dialysis patients.

@nl

prefLabel

A plasma long-chain acylcarnit ...... in incident dialysis patients.

@en

A plasma long-chain acylcarnit ...... in incident dialysis patients.

@nl

P1433

Q37457573-5806F86F-AF71-487E-A420-6FA15A7617E7

P1476

Q37457573-9B035453-BB0E-43F6-A5DF-75AD496EB689

P2093

Q37457573-1CFADF9A-898A-4E25-A276-68136CDF327F

Q37457573-3E127E43-752D-431E-B7BB-A4B4A45391D8

Q37457573-53A80C29-73EB-48BD-A5A9-D36CF1D8018D

Q37457573-70D44B06-3A5B-4738-8108-CA75ACC62D6F

Q37457573-758E0A89-0A58-466D-9139-87C2A94B57E4

Q37457573-77CCAD21-C9CE-4118-A5DB-9673B2ECBE11

Q37457573-96627757-F06D-4FB7-90CC-A0ECB59D5579

Q37457573-A30925EE-7F86-4844-9286-5009703A4595

Q37457573-C5E225D9-231D-4678-B350-6E238ECEFF76

Q37457573-E06860D7-74BD-4CD2-AAE9-5A588AB71D45

P2860

Q37457573-028B6092-47CD-4C65-AAF1-94AC7E8FC68F

Q37457573-028F74D4-5AFD-44E0-91FA-789984F75532

Q37457573-0328248F-9FFE-4B29-9280-D307710C8249

Q37457573-051784B4-BBAF-47DC-9B29-62922BC0094D

Q37457573-06579542-46DC-4461-8EA0-0F19C0179A82

Q37457573-08205CD5-2215-463D-A912-F567444A5485

Q37457573-097DCE99-8169-4644-8FB9-4E8DAACA7898

Q37457573-0AA6B2D9-7192-4991-B700-B3CCFBF8C21C

Q37457573-0BF8E417-0409-4BDF-897D-A9A3050E832D

Q37457573-0F4FBC8C-8D97-4BF9-B5B9-A6BC8222CC02

P304

Q37457573-9F004F68-188A-45F0-AB83-7F000C053B4D

P31

Q37457573-F21A7406-4345-4592-B0D2-D8DEDC608C54

P356

Q37457573-4889AD8C-2848-4CD0-ADE3-7FA03F8F9871

P433

Q37457573-1BF1DE09-37D8-40E0-8C4C-E9C2389880E0

P478

Q37457573-5EF96B32-9BE8-4EAE-A0EF-C96994745D43

P577

Q37457573-A65F25F8-BB27-46B7-9497-D7D99EE0F0D6

P5875

Q37457573-A4E0157D-FDED-41EE-9F87-C6D9BD554909

P698

Q37457573-9583525D-73FF-4CA6-BA91-07DB8E7F698B

P921

Q37457573-38E45294-2C1E-4E86-83E8-09C77E5CFEB0

Q37457573-431C9929-FBC4-4011-B42B-549BE0D31970

Q37457573-596E758E-A51D-46E2-8ED6-CCC95B2116AB

P932

Q37457573-D1843DFC-6C84-4CC7-9150-78AA5C1F06C0

P356

JAHA.113.000542

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

A plasma long-chain acylcarnit ...... in incident dialysis patients.

@en

P2093

Amy Deik

http://www.w3.org/2001/XMLSchema#string

Clary B Clish

http://www.w3.org/2001/XMLSchema#string

Eugene P Rhee

http://www.w3.org/2001/XMLSchema#string

Joseph J Deferio

http://www.w3.org/2001/XMLSchema#string

Julia Wenger

http://www.w3.org/2001/XMLSchema#string

Kerry Pierce

http://www.w3.org/2001/XMLSchema#string

Ravi Thadhani

http://www.w3.org/2001/XMLSchema#string

Robert E Gerszten

http://www.w3.org/2001/XMLSchema#string

Robert W Yeh

http://www.w3.org/2001/XMLSchema#string

Sahir Kalim

http://www.w3.org/2001/XMLSchema#string

P2860

Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

Metabolomics and cardiovascular biomarker discovery

The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Metabolite profiles and the risk of developing diabetes

Why is protein-energy wasting associated with mortality in chronic kidney disease?

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Metabolite profiling identifies markers of uremia.

P304

e000542

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/JAHA.113.000542

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259204774

http://www.w3.org/2001/XMLSchema#string

P698

24308938

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3886735

http://www.w3.org/2001/XMLSchema#string